SUPER
  1. Home
  2. Stocks
  3. LIVEN
  4. Financials

LIVEN · PHARMACEUTICALS

LIVEN financials Liven Pharma Limited

Liven Pharma Limited (LIVEN) has 5 financial years on file, from the year to 30 Jun 2022. The latest, the year to 30 Jun 2026 earned Rs -0.28 a share on sales of Rs 105.8 m. 5 quarters are listed below the years.

Results by financial year

Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 30 June. 5 years and 5 of the last 8 quarters.

Earnings per share by financial year

Jun 22Jun 23Jun 24Jun 25Jun 26-1.18-1.02-7.11-0.281.04
Rupees a share, by year to the month shown. A faded bar is a year whose share count no split or bonus issue explains. Source: the company's filed accounts, latest year to 30 Jun 2026.
YearEarnings per share (Rs)SalesGross marginNet profit as a share of salesChange in earnings per share on the year before
Year to 30 Jun 2026-0.28Rs 105.8 m25.2%-29.4%—
Year to 30 Jun 2025-7.11share count unexplained, left out of growthRs 127.3 m14.1%-459.2%—
Year to 30 Jun 20241.04share count unexplained, left out of growthRs 245.1 m25.5%17.0%—
Year to 30 Jun 2023-1.02share count unexplained, left out of growth————
Year to 30 Jun 2022-1.18share count unexplained, left out of growth————

Results by quarter

5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.

QuarterEarnings per share (Rs)SalesProfit after taxNet profit as a share of salesChange on the same quarter a year before
Quarter to 30 Sep 2026-0.07Rs 14.3 mRs -7.4 m-51.6%—
Quarter to 31 Mar 2026-0.03Rs 29.2 mRs -4.0 m-13.5%—
Quarter to 31 Dec 2025-0.30Rs 54.6 mRs 28.2 m51.7%—
Quarter to 30 Sep 2025-0.28Rs 8.8 mRs -30.2 m-341.9%—
Quarter to 31 Mar 2025-0.10Rs 14.8 mRs -9.6 m-65.2%—

More on LIVEN

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .